Matches in Nanopublications for { ?s ?p "[Primary, metastatic, recurrent and benign ovarian tumors were screened for cyclin E and cdk2 gene amplification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[Primary, metastatic, recurrent and benign ovarian tumors were screened for cyclin E and cdk2 gene amplification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP805433.RAOsJfXsYjtBqmDJHbwd5-LMsbhhKC0ozSLHaUxKGgO14130_assertion description "[Primary, metastatic, recurrent and benign ovarian tumors were screened for cyclin E and cdk2 gene amplification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP805433.RAOsJfXsYjtBqmDJHbwd5-LMsbhhKC0ozSLHaUxKGgO14130_provenance.
- NP1386802.RACtxsMOlMpaOXxWyk8FYR7owbdiIFZbDIG7vQT_lmPtI130_assertion description "[Primary, metastatic, recurrent and benign ovarian tumors were screened for cyclin E and cdk2 gene amplification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1386802.RACtxsMOlMpaOXxWyk8FYR7owbdiIFZbDIG7vQT_lmPtI130_provenance.
- NP300621.RAMGfICZTCTDqTLemIxJJ4iDuLne1SJbVNsJk6WNjoDuI130_assertion description "[Primary, metastatic, recurrent and benign ovarian tumors were screened for cyclin E and cdk2 gene amplification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300621.RAMGfICZTCTDqTLemIxJJ4iDuLne1SJbVNsJk6WNjoDuI130_provenance.
- NP611405.RA4oWCAmTE_gB4u_U4pJv1ZQjfbneKEHsR1Aj9CcTmGUw130_assertion description "[Primary, metastatic, recurrent and benign ovarian tumors were screened for cyclin E and cdk2 gene amplification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP611405.RA4oWCAmTE_gB4u_U4pJv1ZQjfbneKEHsR1Aj9CcTmGUw130_provenance.
- NP1386805.RA_gnJqgNwZwutXKO5NOdD1MqtpjN9V8ncIZSrbKbDj8w130_assertion description "[Primary, metastatic, recurrent and benign ovarian tumors were screened for cyclin E and cdk2 gene amplification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1386805.RA_gnJqgNwZwutXKO5NOdD1MqtpjN9V8ncIZSrbKbDj8w130_provenance.